Related references
Note: Only part of the references are listed.Serum Galectin-2,-4, and -8 Are Greatly Increased in Colon and Breast Cancer Patients and Promote Cancer Cell Adhesion to Blood Vascular Endothelium
Hannah Barrow et al.
CLINICAL CANCER RESEARCH (2011)
Active matrix metalloproteinase-2 activity discriminates colonic mucosa, adenomas with and without high-grade dysplasia, and cancers
Mary Jo Murnane et al.
HUMAN PATHOLOGY (2011)
Galectin-4 functions as a tumor suppressor of human colorectal cancer
Arun Satelli et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Loss of tumoral expression of soluble IL-6 receptor is associated with disease progression in colorectal cancer
Y. Okugawa et al.
BRITISH JOURNAL OF CANCER (2010)
NOTCH Signaling Is Required for Formation and Self-Renewal of Tumor-Initiating Cells and for Repression of Secretory Cell Differentiation in Colon Cancer
Shaheen S. Sikandar et al.
CANCER RESEARCH (2010)
Dangerous liaisons: STAT3 and NF-κB collaboration and crosstalk in cancer
Sergei I. Grivennikov et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2010)
Disease-related expression of the IL6/STAT3/SOCS3 signalling pathway in ulcerative colitis and ulcerative colitis-related carcinogenesis
Yi Li et al.
GUT (2010)
Bifidobacterium lactis Inhibits NF-κB in Intestinal Epithelial Cells and Prevents Acute Colitis and Colitis-associated Colon Cancer in Mice
Seung Won Kim et al.
INFLAMMATORY BOWEL DISEASES (2010)
Persistently Activated Stat3 Maintains Constitutive NF-κB Activity in Tumors
Heehyoung Lee et al.
CANCER CELL (2009)
IL-6 and Stat3 Are Required for Survival of Intestinal Epithelial Cells and Development of Colitis-Associated Cancer
Sergei Grivennikov et al.
CANCER CELL (2009)
An Epigenetic Switch Involving NF-κB, Lin28, Let-7 MicroRNA, and IL6 Links Inflammation to Cell Transformation
Dimitrios Iliopoulos et al.
CELL (2009)
IKK/NF-κB and STAT3 pathways: central signalling hubs in inflammation-mediated tumour promotion and metastasis
Julia Bollrath et al.
EMBO REPORTS (2009)
Interleukin-6 (IL-6) released by macrophages induces IL-6 secretion in the human colon cancer HT-29 cell line
Ying-Ying Li et al.
HUMAN IMMUNOLOGY (2009)
Turning 'sweet' on immunity: galectin-glycan interactions in immune tolerance and inflammation
Gabriel A. Rabinovich et al.
NATURE REVIEWS IMMUNOLOGY (2009)
Autocrine IL-6 signaling: A key event in tumorigenesis?
Sergei Grivennikov et al.
CANCER CELL (2008)
Gene profiling of colonic serrated adenomas by using oligonucleotide microarray
Kyongrae Kim et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2008)
Galectin-4 Controls Intestinal Inflammation by Selective Regulation of Peripheral and Mucosal T Cell Apoptosis and Cell Cycle
Daniela Paclik et al.
PLOS ONE (2008)
MUC1 oncoprotein activates the IκB kinase β complex and constitutive NF-κB signalling
Rehan Ahmad et al.
NATURE CELL BIOLOGY (2007)
Targeting heat shock protein 90 in pancreatic cancer impairs insulin-like growth factor-I receptor signaling, disrupts an interleukin-6/signal-transducer and activator of transcription 3/hypoxia-inducible factor-1α autocrine loop, and reduces orthotopic tumor growth
Sven A. Lang et al.
CLINICAL CANCER RESEARCH (2007)
The MUC1 and galectin-3 oncoproteins function in a MicroRNA-dependent regulatory loop
Selvi Ramasamy et al.
MOLECULAR CELL (2007)
Silibinin suppresses PMA-induced MMP-9 expression by blocking the AP-1 activation via MAPK signaling pathways in MCF-7 human breast carcinoma cells
Syng-Ook Lee et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
MUC1 alters oncogenic events and transcription in human breast cancer cells
Christine L. Hattrup et al.
BREAST CANCER RESEARCH (2006)
Persistent STAT3 activation in colon cancer is associated with enhanced cell proliferation and tumor growth
FM Corvinus et al.
NEOPLASIA (2005)
Immunohistochemical characterization of the distribution of galectin-4 in porcine small intestine
MA Wooters et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2005)
Interleukin 1 activates STAT3/nuclear factor-κB cross-talk via a unique TRAF6-and p65-dependent mechanism
Y Yoshida et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
The role of galectins in the initiation, amplification and resolution of the inflammatory response
N Rubinstein et al.
TISSUE ANTIGENS (2004)
Induced reactivity of intestinal CD4+ T cells with an epithelial cell lectin, galectin-4, contributes to exacerbation of intestinal inflammation
A Hokama et al.
IMMUNITY (2004)
Serum interleukin-6 levels reflect the disease status of colorectal cancer
YC Chung et al.
JOURNAL OF SURGICAL ONCOLOGY (2003)
Interleukin-6 promotes cervical tumor growth by VEGF-dependent angiogenesis via a STAT3 pathway
LH Wei et al.
ONCOGENE (2003)
Galectin-4 in normal tissues and cancer
ME Huflejt et al.
GLYCOCONJUGATE JOURNAL (2003)
The β-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells
M van de Wetering et al.
CELL (2002)
Expression of cyclo-oxygenase-2 in human tongue carcinoma and its precursor lesions
J Renkonen et al.
VIRCHOWS ARCHIV (2002)
Comparative evaluation of the prognostic value of MUC1, MUC2, sialyl-Lewisa and sialyl-Lewisx antigens in colorectal adenocarcinoma
SE Baldus et al.
HISTOPATHOLOGY (2002)
PTEN blocks tumor necrosis factor-induced NF-κB-dependent transcription by inhibiting the transactivation potential of the p65 subunit
MW Mayo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Synergistic stimulation of MUC1 expression in normal breast epithelia and breast cancer cells by interferon-gamma and tumor necrosis factor-alpha
EL Lagow et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2002)
Rat colorectal tumours treated with a range of non-steroidal anti-inflammatory drugs show altered cyclooxygenase-2 and cyclooxygenase-1 splice variant mRNA expression levels
D Vogiagis et al.
CARCINOGENESIS (2001)
Galectins: A new family of regulators of inflammation
FT Liu
CLINICAL IMMUNOLOGY (2000)
Signal transduction by tumor necrosis factor and gene regulation of the inflammatory cytokine interleukin-6
W Vanden Berghe et al.
BIOCHEMICAL PHARMACOLOGY (2000)
Regulation of interleukin-6 gene expression by pro-inflammatory cytokines in a colon cancer cell line
S Legrand-Poels et al.
BIOCHEMICAL JOURNAL (2000)
The COX-2 inhibitor nimesulide suppresses superoxide and 8-hydroxy-deoxyguanosine formation, and stimulates apoptosis in mucosa during early colonic inflammation in rats
D Tardieu et al.
CARCINOGENESIS (2000)
Share Paper
